Sartorius Aktiengesellschaft (OTCMKTS:SARTF - Get Free Report) was the recipient of a large decrease in short interest in May. As of May 31st, there was short interest totalling 1,600 shares, a decrease of 52.9% from the May 15th total of 3,400 shares. Approximately 0.0% of the company's stock are sold short. Based on an average daily volume of 100 shares, the short-interest ratio is currently 16.0 days.
Sartorius Aktiengesellschaft Stock Performance
SARTF stock remained flat at $198.80 during trading hours on Friday. The firm's fifty day moving average is $197.91 and its 200-day moving average is $198.57. The stock has a market cap of $6.80 billion, a price-to-earnings ratio of 150.61 and a beta of 1.12. The company has a debt-to-equity ratio of 1.17, a current ratio of 2.02 and a quick ratio of 1.13. Sartorius Aktiengesellschaft has a 12-month low of $165.00 and a 12-month high of $243.35.
Sartorius Aktiengesellschaft (OTCMKTS:SARTF - Get Free Report) last announced its quarterly earnings data on Wednesday, April 16th. The company reported $1.28 earnings per share for the quarter, meeting the consensus estimate of $1.28. The company had revenue of $959.23 million during the quarter, compared to analysts' expectations of $867.08 million. Sartorius Aktiengesellschaft had a return on equity of 7.33% and a net margin of 2.48%.
Wall Street Analyst Weigh In
Separately, DZ Bank upgraded Sartorius Aktiengesellschaft from a "strong sell" rating to a "hold" rating in a report on Thursday, April 17th.
Check Out Our Latest Analysis on Sartorius Aktiengesellschaft
About Sartorius Aktiengesellschaft
(
Get Free Report)
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers.
Featured Stories
Before you consider Sartorius Aktiengesellschaft, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sartorius Aktiengesellschaft wasn't on the list.
While Sartorius Aktiengesellschaft currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
